Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSF1R | P07333 | 6/20 | 0.40 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.39 |
| ▸ | KIT | P10721 | 1/20 | 0.38 |
| ▸ | FLT3 | P36888 | 1/20 | 0.38 |
| ▸ | CARM1 | Q86X55 | 6/20 | 0.36 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.32 |
| ▸ | BRD4 | O60885 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30224970 | 1.00 | CSF1R (0.40) | CSF1RNPY5RKITFLT3CARM1 | |
| SCHEMBL30182940 | 0.95 | CSF1R (0.42) | CSF1RNPY5RKITFLT3CARM1 | |
| SCHEMBL31022421 | 0.94 | CSF1R (0.40) | CSF1RNPY5RKITFLT3CARM1 | |
| SCHEMBL30183017 | 0.93 | CSF1R (0.41) | CSF1RNPY5RKITFLT3CARM1 | |
| SCHEMBL30224759 | 0.93 | CSF1R (0.40) | CSF1RNPY5RKITFLT3CARM1 | |
| SCHEMBL30224873 | 0.92 | CSF1R (0.40) | CSF1RNPY5RKITFLT3CARM1 | |
| SCHEMBL27237572 | 0.92 | CSF1R (0.40) | CSF1RNPY5RKITFLT3CARM1 | |
| SCHEMBL29185241 | 0.91 | NPY5R (0.41) | NPY5R | |
| SCHEMBL30224934 | 0.91 | NPY5R (0.41) | NPY5R | |
| SCHEMBL29205646 | 0.91 | NPY5R (0.41) | CSF1RNPY5RCARM1P2RY12BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024158205-A1 | INDOLE DERIVATIVE WITH SUBSTITUENT AND PHARMACEUTICAL USE | 주식회사 미토이뮨테라퓨틱스 | 2024-08-02 | — | — | WO | claimed |
| WO-2024158205-A1 | INDOLE DERIVATIVE WITH SUBSTITUENT AND PHARMACEUTICAL USE | 주식회사 미토이뮨테라퓨틱스 | 2024-08-02 | — | — | WO | disclosed |